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Abstract
Background: Humans are increasingly exposed via the diet to Ag nanoparticles (NP) used in the food industry.
Because of their anti-bacterial activity, ingested Ag NP might disturb the gut microbiota that is essential for local
and systemic homeostasis. We explored here the possible impact of dietary Ag NP on the gut microbiota in mice at
doses relevant for currently estimated human intake.
Methods: Mice were orally exposed to food (pellets) supplemented with increasing doses of Ag NP (0, 46, 460 or
4600 ppb) during 28 d. Body weight, systemic inflammation and gut integrity were investigated to determine
overall toxicity, and feces DNA collected from the gut were analyzed by Next Generation Sequencing (NGS) to
assess the effect of Ag NP on the bacterial population. Ag NP were characterized alone and in the supplemented
pellets by scanning transmission electron microscopy (STEM) and energy dispersive X-ray analysis (EDX).
Results: No overall toxicity was recorded in mice exposed to Ag NP. Ag NP disturbed bacterial evenness
(α-diversity) and populations (β-diversity) in a dose-dependent manner. Ag NP increased the ratio between
Firmicutes (F) and Bacteroidetes (B) phyla. At the family level, Lachnospiraceae and the S24-7 family mainly
accounted for the increase in Firmicutes and decrease in Bacteroidetes, respectively. Similar effects were not
observed in mice identically exposed to the same batch of Ag NP-supplemented pellets aged during 4 or
8 months and the F/B ratio was less or not modified. Analysis of Ag NP-supplemented pellets showed that freshly
prepared pellets released Ag ions faster than aged pellets. STEM-EDX analysis also showed that Ag sulfidation
occurred in aged Ag NP-supplemented pellets.
Conclusions: Our data indicate that oral exposure to human relevant doses of Ag NP can induce microbial
alterations in the gut. The bacterial disturbances recorded after Ag NP are similar to those reported in metabolic
and inflammatory diseases, such as obesity. It also highlights that Ag NP aging in food, and more specifically
sulfidation, can reduce the effects of Ag NP on the microbiota by limiting the release of toxic Ag ions.
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Background
Nanomaterials (NM) are widely used in the food indus-
try to take advantage of their very attractive physico-
chemical properties for improving food taste and
texture, increasing nutrient bioavailability, encapsulating
components or controlling the release of flavors. An-
other interesting and growing application of NM is for
covering food processing surfaces and packaging, mostly
to improve their mechanical and antimicrobial proper-
ties [1–3].
Silver nanoparticles (Ag NP) are specifically used for
their antimicrobial properties. More than 400 consumer
products containing Ag NP are currently inventoried by
the project on Emerging Nanotechnologies [4]. Humans
and the environment are, therefore, widely and increas-
ingly exposed to Ag NP. Oral exposure is one of the
main routes of human exposure to Ag NP via their in-
corporation in food products or in coating components
from food processing machine, as well as in plastic food
packaging to prevent bacterial proliferation. In 2009, the
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human dietary intake of silver was estimated at 70–
90 μg/day but this assessment probably underestimates
current exposure levels because of the increasing uses of
Ag NP by the food industry in recent years [5].
Ag NP show limited toxicity on eukaryotic cells,
primarily resulting from increased intracellular levels of
reactive oxygen species and oxidative stress [6]. Animal
studies showed that Ag NP were detected in most or-
gans after oral exposures [7–9]. The in vivo impact of
oral exposure to Ag NP has been investigated in weaned
pigs, rats and mice but the results are not consistent.
After 14 days of exposure to Ag NP in diet, no effects
were detected in the ileal mucosa of pigs but a signifi-
cant increase of body weight (b.w.) was observed [10]. In
contrast, studies in mice and rats noted that Ag NP re-
duced animal growth rate and affected intestinal micro-
villi and liver [9, 11, 12], while others did not find any
influence on the b.w. [13–15]. Park detected toxicity and
inflammation in liver and kidney but no difference in
b.w. [16]. The no observed adverse effect level (NOAEL)
for systemic effects of Ag NP administered orally is
30 mg/kg [11]. On the other hand, Ag NP demon-
strate strong antibacterial functions mainly mediated
by the release of silver ions [17]. Nano-silver is an ef-
fective bactericidal agent against Gram-negative and
Gram-positive strains, its activity depending on the
thickness of the peptidoglycan layer of the bacterial
wall. Silver ions can bind to negatively charged bac-
terial surface and disturb its integrity. Ag NP and
ions can enter bacterial cells and interfere with the
respiratory chain and phosphate uptake. Impaired
DNA replication or protein modifications as well as
strong interactions with cytoplasmic and membrane
thiol-containing proteins are also mentioned as crit-
ical effects of Ag NP in bacteria.
Because of their anti-bacterial activity, ingested Ag
NP could disturb the gut microbiota that is now con-
sidered as an entire metabolic organ with numerous
physio(patho)logical functions [18]. This symbiotic
ecosystem composed of more than 100 trillion bacteria is
essential for intestine maturation, local angiogenesis, regu-
lation of enterocyte gene expression, vitamin synthesis
and homeostasis of innate and adaptive immunity [19, 20].
It is vital that a crosstalk between the host and the micro-
biota is set up just after birth to allow mutual assistance
relationships and to help the host developing and
maintaining a healthy status [21]. The gut microbiota
composition shows intra- and inter- species variations.
It continuously evolves from birth to adulthood and
an alteration in the bacterial balance can occur fol-
lowing changes in the host environment, diet or cir-
cadian rhythm [22–24]. A number of pathological
conditions, including asthma, diabetes, obesity and in-
flammatory bowel disease are associated with alterations
of the gut microbiota composition and functions, also
called dysbiosis [25–29].
Because of the increased potential for consumer ex-
posure to Ag NP, it appeared urgent to assess the pos-
sible impact on the gut microbiota and on human
health. Few studies have investigated this issue and none
are conclusive [10, 30–34]. We used Next Generation
Sequencing (NGS) to investigate the bacterial diversity
of the gut microbiota of mice exposed during 28 d to
dietary doses of Ag NP relevant for currently estimated
daily human intakes.
Results and discussion
Characterization of silver NP
Size, surface area and porosity of Ag NP were deter-
mined by transmission electron microscopy (TEM) and
N2 physisorption. TEM analysis revealed a mean area
equivalent circular diameter of 55.17 ± 2.67 nm and a
right-skewed size distribution shown in Fig. 1a. Individ-
ual and agglomerated Ag NP are shown in Fig. 1b. N2
physisorption revealed that Ag NP were non porous
(porosity 0.027 cm3/g) as shown by a typical type-II
shape adsorption isotherm (Fig. 1c, see Additional file 1
for further explanation) and had a low specific surface
area (5.57 ± 0.08 m2/g).
No overt toxicity in mice orally exposed to Ag NP
Mice were orally exposed to food pellets supplemented
with 0, 46, 460 or 4600 ppb Ag NP (μg Ag NP/kg pellet)
during 28 d. Considering a 20 g mouse consuming an
average of 5 g pellets per day, we aimed to achieve an in-
take of 0, 11.4, 114 and 1140 μg Ag NP/kg b.w./d (target
intake, see Additional file 2: Table S1). The intake of
11.4 μg Ag NP/kg b.w./d was based on the estimated hu-
man dietary intake of silver (70–90 μg/d, i.e. 1.14 μg/kg
b.w./d for a 70 kg man) increased by a factor 10 because
of the likely underestimation, as already mentioned, and
the relatively short exposure duration. Recorded pellet
consumption and b.w. allowed to calculate the effective
intake that was 60–75 % of the target intake (Additional
file 2: Table S1), the highest dose here being below the
levels (1.18 to 36 mg/kg b.w./d) used in previous studies
in pigs, rats and mice [10, 30, 32, 34].
No mortality was recorded. B.w. evolution appeared
constantly and similarly increasing in all groups, indicat-
ing no overt toxicity (Additional file 2: Table S1 and
Additional file 3: Figure S1A). Serum C-Reactive Protein
(C-RP) level, assessed as an overall evaluation of the
possible systemic impact of the treatment, did not show
any significant change in Ag NP-treated groups com-
pared to the controls (Additional file 3: Figure S1B).
Histological analyses did not reveal intestinal damage or
structural alterations: ileal villi were well conserved, gob-
let cells were unaffected and the glycocalyx integrity was
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intact in all experimental groups (Fig. 2a–d). Colonic
tissue was unaffected by the treatment as shown in
Fig. 2e–h. We concluded that Ag NP, at doses used in
this study, did not induce overt local (digestive) or sys-
temic toxicity after 28 d. In rats and mice, previous stud-
ies showed a decrease of b.w. after gavage exposure to
Ag NP and damage to intestinal epithelial cells at doses
5 to 500-fold higher than the highest dose used in the
present study [9, 11, 12] while others showed no differ-
ence in b.w. [13, 14, 16, 30]. Increase in b.w. were only
observed in weaned pigs 14 days after exposure to doses
similar to the highest dose used in the present study
[10]. Differences in experimental conditions (mainly
doses and species, but also modes of administration, NP
size and coating and duration of exposure) could explain
the discrepancies between studies. However, further in-
vestigations with doses relevant for human dietary intake
should be conducted with longer exposure durations to
better assess the effect of Ag NP intake on the b.w.
Ag NP disturb the gut microbiota α-diversity
After 28 d of exposure to food supplemented with Ag
NP, bacterial DNA in mouse feces was analyzed by NGS.
After multiple preprocessing steps (see Methods), an
OTU table including 285 operational taxonomic units
(OTUs) was generated from NGS sequences and α-
diversity indexes were calculated. The α-diversity in-
dexes define the richness (number of OTUs) and even-
ness (relative abundances of OTUs) within a microbial
community either qualitatively (Richness and Chao1 in-
dexes) or quantitatively (Shannon and Simpson indexes).
The Richness (based on the number of OTUs) and
Chao1 (based on the rare OTUs) indexes determine the
richness in a community while the Shannon and
Simpson indexes determine the richness and evenness of
a community [35]. Figure 3a and b indicate that expos-
ure to Ag NP had no significant impact on the richness
of the gut microbiota. However, it slightly but signifi-
cantly decreased the gut microbiota evenness (Fig. 3c
and d), a change that is often related to pathological
conditions and has been associated with obesity [24],
diabetes [32], inflammatory bowel disease [36] and even
asthma [29].
Ag NP dose-dependently disturb gut microbial structure
The diversity between samples (partitioning of diversity
or differences among communities, called β-diversity)
was analyzed by computing a Generalized UniFrac
distance between each sample pair (see Methods). A
UniFrac analysis consists in computing a distance metric
to compare biological communities and which incorpo-
rates information on the relative relatedness of commu-
nity members by incorporating phylogenetic distances
between observed organisms [37]. The principal coordi-
nates analysis (PCoA) of the UniFrac distance matrix en-
abled to visualize the effect of the Ag NP dose on the
microbial structure (Fig. 4a). In addition, the permuta-
tional analysis of variance (ADONIS) performed on the
UniFrac distance matrix showed a significant linear
trend effect of the Ag NP dose on the gut microbial
structure, as shown in the boxplot (Fig. 4b).
Ag NP disturb the gut Firmicutes/Bacteroidetes balance
After taxonomic assignment of the OTUs, the effect of
Ag NP was assessed on the abundance of phyla, families,
and genera. Phyla in control mice were mainly identified
as Firmicutes and Bacteroidetes, which are known to
compose approximately 90 % of the mouse and hu-
man gut microbiota [38, 39]. Exposure to Ag NP sig-
nificantly increased the Firmicutes/Bacteroidetes (F/B)
ratio in a dose-dependent manner (Fig. 5). Since Fir-
micutes are mainly Gram-positive bacteria while Bac-
teroidetes are Gram-negative, this result is consistent
with the observations showing that silver ions are
a b c
Fig. 1 Characteristics of Ag NP. a size (diameter) distribution, b representative micrograph (TEM analysis), c adsorption isotherm (N2 physisorption)
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more toxic to Gram-negative bacteria that have a
thinner wall [17, 40].
In other models, Han also showed that Ag NP inges-
tion increased the proportion of Firmicutes in the gut
microbiota of Drosophila larvae [31] and Das observed a
decrease in the proportion of Bacteroidetes after expos-
ure of a human intestinal bacterial mixture to Ag NP
[33]. A relative increase of Gram-negative bacteria and a
decrease of Firmicutes were observed in rats after
13 weeks of oral gavage with high doses of 10 and
110 nm Ag NP [32]. The latter effects were, however,
not dose- and size- dependent. Two other studies
showed no effect on the gut microbiota of rats [30] and
mice [34] also exposed to high doses of Ag NP. In pigs
exposed to Ag NP, the increase of b.w. was associated
with a reduction of ileal concentration of coliforms while
no difference was detected in the other bacterial groups
[10]. These previous studies have been reviewed by
Pietroiusti [41] and Frölich [42] in an attempt to eluci-
date Ag NP mechanisms of action and explain discrep-
ancies between studies. As already mentioned, this could
be explained by differences in species, modes of admin-
istration (gavage vs diet), doses, NP size and coating, in
vitro or in vivo exposure and duration of exposure.
While gavage was used in all murine studies [30, 32, 34],
oral intake via voluntary consumption in the diet was
preferred in the present study because it represents a
situation closer to human exposure [43]. Like in bacteria
cultured from human stools [33], we observed a relative
decrease in Bacteroidetes. Human and mouse gut micro-
biota are very similar at the phylum level, but not at the
genera or species level [41]. Together with the fact that
we tested doses and a dosing method more relevant for
human dietary intake, this suggests that, at least at the
phylum level, our results could be extrapolated to hu-
man. The transfer of results from animals to humans
could be improved with the use of “humanized” animals
by inoculation of human gut microbiota to gnotobiotic
mice for instance.
The differences of results between studies could also
be related to the techniques used to analyze the micro-
biota [44]. This includes the type of sample and site of
collection, culture-dependent or -independent approach,
and techniques to analyze the microbiota (fluorescence
in situ hybridization FISH, quantitative (q) PCR or
NGS). Many factors can influence the NGS results [44]
but it is unlikely that these differences resulted from the
choice of the NGS platform (Ion torrent versus Illumina
or Roche 454) or the selected hypervariable region in
16 s rRNA gene. It has indeed been shown that different
NGS platforms produced concordant relative abundance
for most micro-organisms when profiling bacterial com-
munity [45] and that using short but well selected region
in 16 s rRNA gene produces phylogenetic information
similar to that obtained from nearly-full-length 16S
rRNA sequencing [46]. However, FISH [10], qPCR
[30, 32] and NGS ([31, 33, 34] and the present study)
are based on totally different approaches: FISH and
qPCR can only detect specific bacteria for which
oligonucleotide probes or primers have been selected
while NGS can in principle detect any bacteria. Consider-
ing studies that analyzed the microbiota by sequencing









Fig. 2 Morphological effects of Ag NP on ileum villi and colonic
mucosa. Tissue was collected from mice exposed during 28 d to Ag
NP. Sections were stained with hematoxylin and eosin. a-d Ileum
villi and cell coat glycocalyx (inserts) and e-h colonic mucosa from
control mice (a, e) and mice exposed to 46 (b, f), 460 (c, g) and
4600 ppb (d, h) Ag NP. Magnification 48.7 x, 320 x and 52 x for
ileum villi, glycocalyx and colonic mucosa, respectively
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at the phylum level [31, 33, 34] and the most recent did
not detect any effect of Ag NP [34].
Although baseline mouse microbiota was homoge-
nized before exposure (see Methods), we cannot exclude
that our data result from cage effects and stochastic
changes over time [47] since all mice from one group
were kept in one single cage (one cage/group). However,
the observed effects are unlikely due to chance only be-






Fig. 3 Alpha-diversity of the gut microbiota in mice orally exposed to Ag NP. α-diversity is presented as richness (a), Chao1 index (b), Shannon
index (c) and Simpson index (d). P-values were obtained with a linear trend test and adjusted with Benjamini-Hochberg method to control
FDR (n = 5)
a b
Fig. 4 Weighted UniFrac distance analysis. a Principal Coordinates Analysis (PCoA) is based on the UniFrac distance matrix generated from all
samples of each group of Ag NP dose (0, 46, 460, 4600 ppb). Control samples tend to form a cluster separated from Ag NP treated samples,
highlighting the proximity and the similarity of their microbial composition within groups and the significant effect of the treatment. b The
boxplot of the UniFrac distances shows that distances between treated samples and the averaged control profile increasing with the dose. This
dose-dependent effect was confirmed by the permutational multivariate analysis of variance (ADONIS) of the weighted UniFrac distance matrix
by assuming a linear trend effect of the Ag NP dose on the microbial structure (p < 0.001, n = 5)
van den Brule et al. Particle and Fibre Toxicology  (2016) 13:38 Page 5 of 16
Data from the present study were also compared to
the effects obtained after treatment with antibiotics.
In the study where they showed no effect of oral Ag
NP on mouse gut microbiota, Wilding observed a sig-
nificant decrease in α-diversity indexes and an in-
crease of the F/B ratio after exposure to a broad
spectrum antibiotic [34]. Other studies also showed a
relative reduction in Bacteroidetes with broad spectrum
antibiotics [48, 49], which indicates that Ag NP can have
similar activities.
Inversion of the gut microbiome F/B ratio has typ-
ically been associated with obesity and overweight in
mice and in humans [50–53]. Transplantation of gut
microbiota from obese animals into the gut of lean
mice induced higher fat gain than transplantation of
the gut microbiota from lean mice. Thus, one might
wonder if Ag NP might promote the development of
obesity. We did not observe any impact of Ag NP on
mice b.w. over a period of 28 d, and it might be
worth considering a longer chronic exposure to Ag
NP that might be needed to lead to a (pathological)
weight gain.
Ag NP disturb the abundance of bacterial families and
genera
Taxonomic assignment identified 23 families among
OTUs. Among all sequences, 99 % were mapped against
OTUs with an assigned family (Fig. 6a). The most abun-
dant families included Deferribacteraceae, Lactobacilla-
ceae, Paraprevotellaceae, Rikenellaceae, Ruminococcaceae,
Bacteroidaceae, Odoribacteraceae, Lachnospiraceae, and
S24 − 7 family. Upon treatment with Ag NP, the decrease
in Odoribacteraceae, Bacteroidaceae and S24-7 family and
the increase in Lactobacillaceae and Lachnospiraceae
accounted for the reduction of Bacteroidetes and increase
of Firmicutes, respectively (Fig. 6b). The S24-7 family
(unknown genus) has been detected in mouse feces in sev-
eral other studies, and represents a high proportion of the
bacterial population [54–57]. This family is poorly charac-
terized. A very recent study suggested that S24-7 could act
as a protective factor against diabetes [58]. In Drosophila
larvae, gut Lactobacillaceae were also increased by Ag
NP [31].
Taxonomic assignment identified 24 genera among
OTUs. Among all sequences, 56 % were mapped against
Fig. 5 Abundance of bacterial phyla in the gut microbiota after exposure to Ag NP. a Relative abundance of the main phyla averaged for each
group of Ag NP dose (0, 46, 460, 4600 ppb). b-d Scatter plots obtained for the most abundant phyla (average relative abundance ≥ 1 % in at
least one group). P-values were obtained with a linear trend test and adjusted with Benjamini-Hochberg method to control FDR (n = 5)
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Fig. 6 Abundance of bacterial families in the gut microbiota after exposure to Ag NP. a Relative abundance of the main families averaged for
each group of Ag NP dose (0, 46, 460, 4600 ppb). b Scatter plots obtained for the most abundant families (average relative abundance≥ 1 % in
at least one group). P-values were obtained with a linear trend test and adjusted with Benjamini-Hochberg method to control FDR (n = 5)
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OTUs with an assigned genus (Fig. 7a). S24-7 family
accounted for most unidentified Bacteroidetes. Relative
abundance of Bacteroides genera was reduced by the Ag
NP treatment, and Coprococcus, Lactobacillus and
Blautia were increased (Fig. 7b). Our data present simi-
larities with several mouse studies showing that high fat
diet induces an increase of the Clostridiales order (that
includes the family Lachnospiraceae strongly increased
in the present study) and a decrease of the Bacteroidales
order (that includes Bacteroides genera decreased here)
[28, 59]. In humans, Bacteroides are decreased and
Coprococcus increased in obese individuals [28, 50].
However, opposite results on Bacteroides were also ob-
served in other studies [28, 60]. Overall, our data show
that oral exposure to Ag NP dose-dependently decreases
bacterial α-diversity and disturbs taxonomic balance.
Effect of Ag NP ageing in food
Ag NP are known to be highly dynamic in organic envi-
ronments and food is not necessarily ingested directly
after contact with Ag NP. Therefore, we studied the ef-
fect of the same batch of Ag NP-supplemented pellets in
an experiment repeated under the same conditions 4
and 8 months later, i.e. approximately 4 and 8 months
after the incorporation of Ag NP in the pellets. In the
second experiment (4 months later), we observed that
Ag NP significantly altered gut microbiota (see PCoA in
Fig. 8a and b). However, the dose-dependent inversion
of F/B balance was less clear with a non-significant de-
crease of Bacteroidetes (p = 0.08) and a non-significant
increase of Firmicutes (p = 0.11) (Fig. 8c). In the third
experiment (8 months after the first experiment), no sig-
nificant effect of Ag NP was detected and an inversion
of F/B balance was not observed (Figs. 8f–j). As the re-
lease of Ag ions, related to NP dissolution, is considered
so far as the major mechanism of Ag NP toxicity in bac-
teria [61], we explored whether alteration of Ag NP over
time could explain the discrepancies between these 3
experiments.
Ag sulfidation in aged pellets
We compared the dissolution of newly-acquired Ag NP
to that of 8-month old Ag NP conserved in air (not in
food pellets). Over a period of 21 d, we did not observe
any difference in Ag+ release (Fig. 9a). We then assessed
the release of Ag ions from freshly prepared (new) and
8-month old (aged) pellets supplemented with Ag NP.
As shown in Fig. 9b, aged pellets released Ag+ less rap-
idly than new ones. Thus Ag ions were less bioaccessible
in pellets used in the 3rd experiment than in those used
in the 1rst experiment.
Sulfidation of Ag NP is known to occur in the envir-
onment, even if NP are coated with PVP, and to reduce
dissolution rate and modify surface charge [62]. This
sulfidation was shown to decrease Ag NP toxicity to
bacteria, fish, nematodes and plants [61, 63]. We then
studied Ag sulfidation in aged pellets by scanning trans-
mission electron microscopy (STEM) and energy disper-
sive X-ray analysis (EDX). Ag NP observed in 8-month
old supplemented pellets showed the concomitant
presence of Ag and S (Fig. 9c–f ). Ag NP that had not
been mixed with pellets did not show any sulfur (Fig. 9g
and h). Thus, Ag NP solubilization and alteration of the
gut microbiota decreased along with Ag NP sulfidation
and time spent in contact with food, suggesting that Ag+
release is probably an important component of the Ag
NP toxicity for the gut microbiota, although we cannot
exclude that effects could also be mediated by the nano-
particle form. Sulfidation is a major transformation
process for Ag NP in contact with organic materials
containing thiols, sulfur-containing amino acids or pro-
teins. Sulfidation of Ag NP has been reported in waste-
water treatment systems [64], soils [65] or cell culture
media [66]. To the best of our knowledge, this study is
the first to report sulfidation of Ag NP in food. How this
observation can be translated to human exposure sce-
nario will vary according to food composition and dur-
ation of contact with Ag NP. Moreover, although most
previous studies with Ag NP were performed by gavage
(no incorporation of Ag NP to food), it cannot be
excluded that, in some studies, Ag NP samples were
inactivated by sulfidation and that this could explain in-
consistent results. We, therefore, recommend that the
sulfidation state of Ag NP samples be systematically doc-
umented in future studies.
Conclusions
Our data indicate that oral exposure to Ag NP at doses
relevant for human dietary intake can induce microbial
alterations in the gut. It suggests that Ag NP aging in
food, and more specifically sulfidation, can reduce the
effects on the microbiota and that the potential risk of
microbial alteration from human exposure to Ag NP in
foods or food containers is likely to relate to the ability
of Ag NP to release silver ions. It appears, therefore, ne-
cessary to assess the degree, rate and duration of Ag+ re-
lease over time and under likely exposure conditions for
predicting the potential of new Ag NP-containing prod-
ucts to alter microbial communities.
This study also highlights that Ag NP can induce gut
microbial alterations, specifically an increased F/B ratio,
similar to that described in association with obesity and
inflammatory diseases, as well as with antibiotic admin-
istration. However, the 28-day protocol applied in the
present study did not detect systemic impacts or in-
creased weight gain associated to microbial alterations
induced by Ag NP. Further investigations should be con-
ducted with longer exposure durations and using
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Fig. 7 Abundance of bacterial genera in the gut microbiota after exposure to Ag NP. a Relative abundance of the main genera averaged for
each group of Ag NP dose (0, 46, 460, 4600 ppb). b Scatter plots obtained for the most abundant genera (average relative abundance≥ 1 % in at
least one group). P-values were obtained with a linear trend test and adjusted with Benjamini-Hochberg method to control FDR (n = 5)







Fig. 8 Effect of aged Ag NP supplemented pellets on the gut microbiota. Gut microbiota analysis of mice orally exposed during 28 days to 4-month
(A-E, n = 3) and 8-month (F-J, n = 5) old Ag NP supplemented pellets. a, f PCoA based on the UniFrac distance matrix, b, g boxplots of the UniFrac
distances, c, h relative abundance of the main phyla, d, i families and e, j genera





Fig. 9 (See legend on next page.)
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Polyvinylpyrrolidone (PVP)-coated Ag NP particles were
obtained from Sigma-Aldrich (Silver 576832-5G, Vial #
MKBN3581V, MO, USA). NP purity was 99.5 % and
PVP coating represented 0.2 %, as stated by the provider.
NP surface area, porosity and size were characterized by
N2 physisorption and TEM, respectively (see Additional
file 1).
Preparation of pellets supplemented in Ag NP
Mouse food, i.e. lab pellets from Carfil (Rats & Mice
Maintenance, Oud-Turnhout, Belgium), was supple-
mented with 0, 46, 460 or 4600 ppb Ag NP by the pro-
vider using appropriate aliquots of Ag NP incorporated
during the preparation of the pellets to reach the target
NP concentrations. Food bags were γ-irradiated and
stored at room temperature, in dark and dry conditions.
Solubilization of Ag from Ag NP and pellets
Aged (8 months) and newly prepared pellets supple-
mented with Ag NP (46 ppb), pristine (control) pellets,
aged (8 months) and new Ag NP were suspended in
10 ml NaNO3 0.01 M (pH7), incubated under slow rota-
tion at room temperature during 4 weeks. Aliquots were
collected at different time points, centrifuged at 12000 g
and supernatants were analyzed by inductively coupled
plasma mass spectrometry (ICP-MS) for Ag content.
Ag and S co-localization in Ag NP-supplemented pellets
Pellet samples first ground into fine powder or Ag NP
were diluted in pure EtOH. Three μL of solution was de-
posed on a carbon grid fil (Ted Pella 1824) first prepared
to avoid agglomeration using glow discharge plasma
(Ar/O2, 25 W, 20 s). TEM carbon films were then ob-
served on a Tecnai Osiris TEM commercialized by FEI.
Images were recorded in STEM mode. Images were re-
corded using a HAADF detector (High Angle Annular
Dark Field). This detector gives a contrast proportional
to the mean Z of the element and the thickness of the
sample. EDX acquisition was carried out in STEM mode
(a probe size of approximately 5 Angström, probe
current of 0.4 nA) and the 4 detectors of the system.
The solid angle is thus close to 1 srad. Spectra images
were recorded for each sample and element identifica-
tion was carried out on a representative area of the sam-
ple. Acquisition time was 10 min.
Animals and experimental design
Experiments were set up according to OECD guideline
407 for testing of chemicals (“Repeated dose 28-d oral
study in rodents”). Three month old C57BL/6 female
mice, locally bred under SPF-like conditions (Animalerie
Centrale, Université catholique de Louvain, Brussels,
Belgium) in a controlled environment (22 °C, 55 % rela-
tive humidity, 16-h light/8-h dark cycle, with acidified
water and food ad libitum) were housed in autoclaved
air-filtered polycarbonate cages with conventional saw-
dust (Carfil). Litters were mixed every day for one week
before exposure to homogenize the baseline gut micro-
biota [67]. Mice were then randomly assigned to experi-
mental groups (one cage/dose group) and fed with
control or Ag NP-supplemented pellets, i.e. orally ex-
posed to food supplemented with 0, 46, 460 or 4600 ppb
Ag NP (μg Ag NP/kg pellet), during 28 d. A single
experimenter took care of the animals during the ex-
perimental period. Control pellets were not supple-
mented with free PVP since this might not represent
PVP coated on particles and since PVP is not ex-
pected to have any effect on mammalian cells, nor on
bacteria [68, 69].
Mice were weighed prior to and twice a week during
the experimental period and food consumption was re-
corded per cage to calculate the actual Ag NP daily in-
take. After 28 d exposure, mice were euthanized by an
intra-muscular injection of 60 mg of pentobarbital and
intra-cardiac blood was collected. The 3 distal centime-
ters of the ileum, the caecum, and the 3 proximal centi-
meters of the colon were excised. Intestines were
opened longitudinally and their content was gently re-
moved by scraping. Those 3 feces samples were col-
lected and pooled per mouse, and stored at −20 °C until
DNA extraction. The outer side of the gut tissues was ap-
plied against blotting paper which was then submerged in
10 % formaldehyde, inner side downwards, allowing intes-
tinal villi to stretch with gravity. Hematoxylin-eosin
(H&E) staining was performed on 5 μm thick intestinal
sections.
All animal experiments were performed in accordance
with local and institutional ethical guidelines.
(See figure on previous page.)
Fig. 9 Ag solubilization and sulfidation in Ag NP supplemented pellets. Kinetics of Ag solubilization from a aged and new Ag NP and in b aged
(8 months) and freshly prepared Ag NP-supplemented and control pellets. c-h Elemental maps of Ag NP pellets and Ag NP acquired in STEM
mode. c HAADF image of Ag NP pellets. Fours NP are visible (indicated by arrows). d EDX Ag and S profiles, e Ag and f S maps of Ag NP pellets
acquired from EDX analysis. g HAADF image and h Ag map acquired from EDX analysis of Ag NP alone
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Serum analyses
Serum C-Reactive Protein (C-RP) was measured by a
magnetic Luminex screening assay according to manu-
facturer’s instructions (R&D Systems, Minneapolis,
USA) on a Bio-Plex 200 analyzer (Bio-Rad, Hercules,
California, USA).
DNA extraction and 16 s rRNA gene sequencing
Feces DNA was extracted with a QIAamp DNA Stool
Mini kit according to manufacturer’s guidelines (Qiagen,
Hilden, Germany), except for DNA elution with sterilized
PCR-grade water (Merck, Darmstadt, Germany). DNA
concentrations were calculated on a Qubit Fluorometer
(Invitrogen, Gent, Belgium) with a Qubit dsDNA HS
Assay kit. DNA samples were stored at −20 °C until NGS
analysis at MR DNA lab (Shallowater, USA).
The gut microbial populations were identified and
quantified on an Ion Torrent Personal Genome Machine
(PGM) (Life technologies, USA). Specific primers of the
16S rRNA gene V4 variable region (forward GTG
CCAGCMGCCGCGGTAA and reverse GGACTACHV
GGGTWTCTAAT [70]) were used in a PCR with the
HotStarTaq Plus Master Mix Kit (Qiagen) under the fol-
lowing conditions: 94 °C 3 min, (94 °C 30 s, 53 °C 40 s,
72 °C 1 min) x28, 72 °C 5 min. PCR was made in a
single-step, meaning that a sample-specific barcode and
a global primer was added to each amplicon which were
all sequenced in a single run on an Ion Torrent PGM
following the manufacturer’s guidelines.
NGS data analysis
Raw sequences generated by the NGS experiments were
processed using USEARCH v8.0.1623 (Tiburon, USA)
for linux in order to perform a de-novo OTU clustering
analysis [71, 72]. A quality filtering step was applied in
order to keep sequences with an expected number of
errors <1.5 and a length >150 nt. After the dereplication
and the sorting of the remaining sequences, the latter
were clustered into representative OTUs using a radius
percentage of 3.0. The resulting OTUs were then
scanned to detect and to remove the chimera. These
steps were performed on a pool of sequences generated
by all samples from the 3 experiments (0, 4, and
8 months), as recommended in the USEARCH manual
in order to make the results of each experiment compar-
able. The quality-filtered sequences from all samples of
each experiment were mapped against the non-chimeric
OTUs (n = 343) and one OTU table was therefore gener-
ated for each experiment.
The taxonomic assignment of each OTU was carried
out using a local BLAST against the Greengenes data-
base version 13.5 [73]. The Greengenes database was di-
vided into 4 sub-databases according to the level of
taxonomic definition (genus, family, order, phylum). The
taxonomic assignment of each OTU was based on a
blast hit at the species, genus, family or order level if
a > 97 %, > 95 %, > 90 % or > 85 % identity was found
in the corresponding databases, respectively.
The OTU tables and the OTU taxonomic assignments
were the starting point of the downstream analyses
which were performed using the R software (version
3.1.2., Vienna, Austria). A second level of quality-filtering
based on OTU abundance was carried out to discard
those OTUs with a number of sequences <0.005 % of the
total number of sequences, as recommended before [74].
This second level of quality-filtering resulted into an OTU
table including 285 OTUs. After rarefaction, the α-
diversity indexes (Richness, Chao1, Simpson and
Shannon) were computed for each sample with the
phyloseq R package [75] while the β-diversity, which
involves the assessment of dissimilarity between the
composition of communities by taking into account
the evolutionary relationship between sequences, analyses
were carried out by computing weighted UniFrac dis-
tances with the GUnifrac R package [76]. The UniFrac
analysis was based on a phylogenetic tree of the OTUs
which was obtained with the UPGMA algorithm after
OTU sequence alignment with MUSCLE function [77]
from the muscle R package. The α parameter of the
weighted UniFrac distance analysis was set to 0.5 in order
to avoid that distances be dominated by highly abundant
lineages. The weighted UniFrac distance matrix was visu-
alized using a principal coordinates analysis (PCoA) with
the cmdscale function from the GUnifrac R package. In
addition, the ADONIS function of the same package was
used to perform a permutational multivariate analysis of
variance of the weighted UniFrac distance matrix in order
to detect the association between the Ag NP dose and the
β-diversity.
The association between Ag NP dose and each out-
come (including α- and β-diversities as well as phyla,
family and genera relative abundance) were assessed via
linear trend effects which were computed using linear
regression model by assuming equally spaced groups (0,
46, 460, and 4600 ppb). When the effect of the Ag NP
dose was assessed on multiple outcomes (e.g. 11 family
relative abundances or 4 α-diversity measures), p-values
were corrected with the Benjamini-Hochberg method in
order to control the False Discovery Rate (FDR) [78],
and the significance threshold for the adjusted p-values
was set at 0.05.
Additional files
Additional file 1: Methods. (PDF 48 kb)
Additional file 2: Table S1. Oral exposure to Ag NP and mouse final
b.w. (PDF 36 kb)
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Additional file 3: Figure S1. B.w. and blood C-RP responses in mice
orally exposed to Ag NP during 28 d. C57BL/6 female mice were
orally exposed to food supplemented with 0, 46, 460 or 4600 ppb nAg
during 28 d. (A) B.w. were measured on d 0 prior to first exposure
and twice a week during the experimental period. (B) C-RP was
quantified in serum by Luminex. Graphs represent means ± SEM
(n = 3-5). (PDF 38 kb)
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